Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
Insider Trades
|
Expensive Performer
6360.5000
-30.00
(
-0.47
%)
NSE
Dec 30, 2025
15:31 PM
28.37% Gain from 52W Low
Volume:
1.9M
High volume today
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
13 Aug 2022
Insider Trades
6360.50
-0.47%
Divi's Labs (HOLD): No respite in sight for margins
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4250
BOB Capital Markets Ltd.
Q1 revenue broadly in line with consensus at Rs 22.5bn (+15% YoY/-10% QoQ), but EBITDA 10% below
Divi's Laboratories Ltd. is trading at high day volume of 1.9M.
More from Divi's Laboratories Ltd.
Recommended
Market closes flat as gains in metal & auto stocks offset losses in other sectors
Trendlyne Marketwatch |
30 Dec 2025, 04:11PM
IPO activity is high on listings, but low on subscriptions
|
29 Dec 2025, 05:02PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022